Quantcast Smart Matrix Limited | Downing

Smart Matrix Limited


Smart Matrix®, a new potential treatment for full thickness skin wounds, was created by award winning medical research charity RAFT (Restoration of Appearance and Function Trust) to answer the concerns raised by surgeons about the inadequacies of current treatments. Over 50 million ‘hard to close’ wounds are treated annually, worldwide in what is a multi-billion $ industry. Smart Matrix Ltd effectively owns all the rights to Smart Matrix®, including taking this indication through the development phase and into patients. Using funds invested to date, clearance has been received from the MHRA (Medicines and Healthcare Products Regulatory Agency) to undertake human trials and the first clinical trial commenced in August 2015. In the words of surgeons and patients, the results have been ‘astounding’ and the potential to be a real ‘game-changer’ in the world of wound healing.

Smart Matrix Ltd is now organising the final clinical trial to investigate the efficacy of Smart Matrix® to heal wounds without a Split Thickness Skin Graft which would make Smart Matrix® a unique product in the market place. Smart Matrix Limited will then pursue granting of a CE mark and FDA approval.

Downing has invested £430K into Smart Matrix across multiple fund raisings.

Important Notice

Investing in our products will place your capital at risk and you may not get back the full amount invested. Any tax treatment may be subject to change and the availability and value of the reliefs depend on the individual circumstances of each investor. The availability of tax reliefs also depends on the investee companies maintaining their qualifying status.

Further information can be found at HMRC’s website. Neither past performance or forecasts are reliable indicators of future results and should not be relied upon. Unquoted or smaller company shares are likely to have higher price fluctuations and are likely to be more difficult to sell than shares quoted on the London Stock Exchange Official List. Website content is not intended to constitute investment, tax or legal advice. We recommend you seek independent advice before investing in any of our products.

Important Notice

Downing’s investments place your capital at risk and you may not get back the full amount invested. Past performance and forecasts are not a reliable guide to future results. Tax treatment may be subject to change and depends on individual circumstances. Smaller company shares are likely to have higher volatility and liquidity risks than other types of main market listed instruments. We recommend that you seek professional independent financial advice before investing. We do not offer investment or tax advice.

By clicking below you confirm you have read and understood the information above.